Cargando…
How innovative are new drugs launched in the UK? A retrospective study of new drugs listed in the British National Formulary (BNF) 2001–2012
OBJECTIVES: Innovative new drugs offer potential benefits to patients, healthcare systems, governments and the pharmaceutical industry. Recent data suggest annual numbers of new drugs launched in the UK have increased in recent years, and we sought to understand whether this represents increasing nu...
Autores principales: | Ward, Derek J, Slade, Angharad, Genus, Tracey, Martino, Orsolina I, Stevens, Andrew J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212185/ https://www.ncbi.nlm.nih.gov/pubmed/25344485 http://dx.doi.org/10.1136/bmjopen-2014-006235 |
Ejemplares similares
-
Decline in new drug launches: myth or reality? Retrospective observational study using 30 years of data from the UK
por: Ward, Derek J, et al.
Publicado: (2013) -
Trends in clinical development timeframes for antiviral drugs launched in the UK, 1981–2014: a retrospective observational study
por: Ward, Derek J, et al.
Publicado: (2015) -
British national formulary /
Publicado: (2003) -
Time to potential for listing of new drugs on public and private formularies in Canada: a cross-sectional study
por: Lexchin, Joel
Publicado: (2022) -
Did the accuracy of oral amoxicillin dosing of children improve after British National Formulary dose revisions in 2014? National cross-sectional survey in England
por: Rann, Olivia, et al.
Publicado: (2017)